Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Yuan Yuan Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-9540-2100; OpenAlex author ID A5113577754. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper

Papers 7

  1. The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma. Co-author DOI 10.7717/peerj.9736↗
  2. Prognostic values of 18F-FDG PET/CT metabolic parameters and clinical figures in locally advanced pancreatic cancer underwent chemotherapy combined with stereo… Co-author DOI 10.1097/md.0000000000015064↗
  3. AQP1 and AQP3 Expression are Associated With Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/pai.0000000000000523↗
  4. Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s12253-017-0284-5↗
  5. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. Last author DOI 10.3233/cbm-160655↗
  6. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-015-3752-0↗
  7. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma. Last author DOI 10.3233/cbm-150515↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiong Zou · 5 shared papers, 2015–2019 · strength 0.38
  2. Xiongying Miao · 3 shared papers, 2015–2016 · strength 0.17
  3. Leping Yang · 2 shared papers, 2015–2016 · strength 0.11
  4. Wen Zou · 1 shared paper, 2019 · strength 0.11
  5. Bing Qi · 1 shared paper, 2020 · strength 0.11
  6. Han Liu · 1 shared paper, 2020 · strength 0.11
  7. Lei Yao · 1 shared paper, 2020 · strength 0.11
  8. Xueying Shi · 1 shared paper, 2020 · strength 0.11
  9. Shilin Xia · 1 shared paper, 2020 · strength 0.11
  10. Shengnan Ren · 1 shared paper, 2019 · strength 0.10
  11. Changjing Zuo · 1 shared paper, 2019 · strength 0.10
  12. Anyu Zhang · 1 shared paper, 2019 · strength 0.10
  13. Lingong Jiang · 1 shared paper, 2019 · strength 0.10
  14. Xiao Li · 1 shared paper, 2019 · strength 0.10
  15. Xiaofei Zhu · 1 shared paper, 2019 · strength 0.10
  16. Huilan Xu · 1 shared paper, 2018 · strength 0.09
  17. Liangliang Yang · 1 shared paper, 2018 · strength 0.09
  18. Hongliang Yao · 1 shared paper, 2016 · strength 0.06
  19. Chun Liu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.